ArticleNPJ precision oncology2022

A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy.

Timothy Rajakumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.